The Retinal Cancer Treatment - Oren Zarif


The two most common forms of treatment for Retinal Cancer are surgeries and chemotherapy. Surgery is a very broad category and includes laser surgery, conventional surgery and vitrectomy/stenoidectomy. Lasers have revolutionized eye care and are being used in a wide range of eye care issues. The technology is rapidly advancing and surgery is no exception. If you or a family member suffers from any type of eye cancer, you should contact your doctor about the treatment options available.


Eye tumors can be difficult to treat because they grow slowly and frequently return. This is why many cancer researchers are focusing their efforts on finding a better way to treat these stubborn tumors. Researchers know that they cannot simply kill off every single one of these disease-cells, but they can learn how to target and defeat specific subsets of cells. One idea for retinal cancer treatment is using genetically engineered mice. This method has shown promise in treating several types of tumors including glaucoma, choroid, retinal pigment epithelial, choroidal and retinoic acid. Some of these mice have already completed test campaigns and are now ready to enter human clinical trials.


Zarif prepares the Bosmat and delivers it globally for patients who are incapable of flying in order to receive their treatment

The purpose of the Bosmat treatment is to open the blocked and locked areas of the body's energy field, so that the body will be able to create a healing process for existing symptoms that the patient suffers from.

For years, Oren Zarif proved that as the energy blocks open, the body begins to create a healing process and returns to its strength, thousands of patients testify for it.

A specific delivery system has also been developed by scientists to help destroy retinal cancer cells without harming healthy tissue. This method uses a virus to attach itself to cancer cells and then make them die. The virus then releases a chemical that vaporizes the remaining cells in an instant. This vaporization process has already been tested on human glaucoma patients, and it appears to have worked quite well.


Another gene therapy being tested in humans is termed "intramuscular gene delivery". It works by injecting specially engineered genes directly into the eye, where they control the growth of new retinal cells. The eye will be protected from any damage caused by chemotherapy and other retinal disorders.

The final gene being experimented with in humans is the rb1 gene accelerator. It stimulates the production of the protein fibrosis, which normally slows the growth rate of fibroblasts, but which is the main cause of retinal degeneration in most patients. Because this type of stimulation is safe and non-invasive, it is currently being tested on animals. If it proves successful, it may one day be used to treat all forms of retinal degeneration, not just the classic form of glaucoma.


Retinal cancer is a frightening disease, which can take the lives of thousands every year. Thanks to advances in biotechnology company research, we may soon be able to take care of our greatest hopes for a world-first treatment for this terrible disease. Whether the company develops a drug that can cure all forms of retinal degeneration or a drug that simply stuns the disease process, the company is on the right path. Finding a cure is only a matter of time, and the research is only in its beginning stages. Don't wait for your own life to be lost; get in touch with a biotechnology company to help get it started.